What Researchers Did
Researchers investigated the effect of hyperbaric oxygenation (HBO) in 64 patients with parkinsonism of various etiologies.
What They Found
A beneficial effect was observed in 55 out of 64 patients (86%) who received daily HBO sessions. Treatment outcomes were more favorable in patients with vascular parkinsonism, those under 65 years old, and individuals with a disease duration of 1-5 years, with the akinetic-rigid syndrome showing greater regression than trembling hyperkinesis.
What This Means for Canadian Patients
Canadian patients with parkinsonism, particularly those with vascular etiology or early-stage disease, might potentially benefit from hyperbaric oxygenation as an adjunctive therapy. However, further research is needed to confirm these findings and establish its role in current treatment protocols.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in Russia and does not involve Canadian researchers or patients.
Study Limitations
A key limitation of this study is the absence of a control group, which prevents definitive conclusions about the efficacy of hyperbaric oxygenation compared to standard care or placebo.